Without doubt, Carnival Corporation (NYSE: CCL) did not have a good year in 2020. The COVID-19 pandemic halted its operations and negatively
Carnival Corporation (CCL): Despite headwinds, there is a positive sentiment around the stock
Categories
Trending Stocks
Moderna (MRNA): Development programs, additional approvals provide optimism
Moderna Inc. (NASDAQ: MRNA) seems to be on a roll right now. The stock has skyrocketed over 500% in the past one
Tata Motors’ (TTM) stock gains traction amid sales updates and partnership rumors
Shares of Tata Motors Ltd. (NYSE: TTM) were up 4% in morning hours on Tuesday. The stock has been making a buzz
NIO (NIO) generates quite some buzz after a successful NIO Day
NIO Inc. (NYSE: NIO) saw its shares jump 9% on Monday after the company unveiled its new vehicle model along with other
Moderna’s (MRNA) stock gains on COVID-19 vaccine approval from the European Commission
Shares of Moderna Inc. (NASDAQ: MRNA) gained 6.3% in afternoon hours on Wednesday as the company received approval from the European Commission
General Motors (GM) reports strong sales growth for Q4 but full-year sales see a drop
General Motors Co. (NYSE: GM) reported strong sales growth in the US for the fourth quarter of 2020 but full-year sales declined.
Nio (NIO) ends 2020 on a high note with triple-digit growth in deliveries
Nio Inc. (NYSE: NIO) reported strong growth in deliveries for the month of December, the fourth quarter and the full year of
Digital forms key part of Lululemon’s (LULU) strategy for holiday season and beyond
Shares of Lululemon Athletica Inc. (NASDAQ: LULU) were up 5% during midday trade on Thursday. The stock has gained 64% since the
Eli Lilly (LLY) is paving the way to a strong 2021
Shares of Eli Lilly & Co. (NYSE: LLY) were up over 2% on Wednesday. The stock has gained over 30% since the
American Outdoor Brands (AOUT) gains from rising interest in outdoor activities and personal protection
American Outdoor Brands Inc. (NASDAQ: AOUT) saw its stock climb over 17% in morning hours on Wednesday. The stock has gained 38%
Starbucks (SBUX) aims to expand its store fleet to more than 50,000 stores by 2030
Starbucks Corp.’s (NASDAQ: SBUX) shares gained over 5% on Thursday benefiting from the upbeat guidance provided by the company a day ago.
One key stock you need to track ahead of COVID-19 vaccine approvals
It's been a spectacular year for many biotech and pharma investors who have made a killing out of the COVID-19 vaccine rally.
Is it time to book profits from Moderna?
Moderna (NASDAQ: MRNA) stock has soared a staggering 679% since the beginning of this year. If you did identify the potential of
AdaptHealth (AHCO) gains on AeroCare acquisition announcement
Shares of AdaptHealth Corp. (NASDAQ: AHCO) surged 15% in morning trade on Tuesday after the company announced its decision to acquire privately-held
Nikola’s (NKLA) stock crashes on reworked agreement with General Motors (GM)
Shares of Nikola Corporation (NASDAQ: NKLA) plummeted over 26% in afternoon trade on Monday after its previously announced agreement with General Motors
Retail: Online sales stand strong during this holiday season
The retail industry took a significant hit this year due to the COVID-19 pandemic but it also saw a rapid shift to
Walt Disney (DIS): After a tough FY20, the pandemic is likely to take a toll on operations next year too
The Walt Disney Company (NYSE: DIS) had a tough time in fiscal year 2020 with the COVID-19 pandemic bringing its operations to
Merck (MRK) acquires OncoImmune to add another drug to its COVID-19 pipeline
Merck (NYSE: MRK) announced the acquisition of privately-held biopharma company OncoImmune for an upfront payment of $425 million in cash with subsequent
Pfizer concludes COVID-19 vaccine trial with efficacy of 95%; will apply for EUA within days
Pfizer Inc. (NYSE: PFE) and its partner BioNTech SE (NASDAQ: BNTX) announced the completion of the Phase 3 clinical trial of their
Moderna (MRNA) gains as COVID-19 vaccine candidate shows over 94% efficacy
Shares of Moderna Inc. (NASDAQ: MRNA) were up over 8% in morning trade on Monday as the company reported positive results from
Pfizer (PFE) gains on data showing 90% efficacy for COVID-19 vaccine candidate
Shares of Pfizer Inc. (NYSE: PFE) rallied on Monday after the company reported positive results from its Phase 3 trial for its